View all cases
- Case details
- Status—ActionProcedural applicationCategoryOther procedural
- Parties
- Claimants
- Sanofi Mature IPOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
Respondents- Accord Healthcare S.L.U.Operating co.
- Accord Healthcare GmbH (AT)Operating co.
- Accord Healthcare B.V.Operating co.
- Accord Healthcare GmbH (DE)Operating co.
- Accord Healthcare Italia SrlOperating co.
- Accord Healthcare, Unipessoal Lda.Operating co.
- Accord Healthcare ABOperating co.
- STADAPHARM GmbHOperating co.
- STADA Arzneimittel AGOperating co.
- STADA Nordic ApSOperating co.
- Reddy Pharma SASOperating co.
- betapharm Arzneimittel GmbHOperating co.
- Dr Reddy's SrlOperating co.
- Zentiva FranceOperating co.
- Zentiva Pharma GmbHOperating co.
- Zentiva, k.s.Operating co.
Representatives- Jules Fabre-Pinsent Masons
- Daniel Hoppe-Bonabry
- Christian Meyer-Maiwald
- Anja Lunze-Taylor Wessing
- Arjan Reijns-Pinsent Masons
- Louise Millot-Pinsent Masons
- Andreas Ledl-Maiwald
- Elisabeth Greiner-df-mp
- Division
- Munich LD
- Judges
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- Jan 7, 2025
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
At the UPC: Sanofi Group (33 cases)·Accord Group (8 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 24 other proceedings
UPC CoA 22/2026·UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 25/2026·UPC CoA 26/2026 and 19 more
Decisions
- 2025-01-07Application RoP305Public
Summary: The Munich Local Division judge-rapporteur issued a procedural order in the Sanofi pharmaceutical infringement actions (UPC_CFI_145-148/2024) granting the substitution of Sanofi-Aventis France by Sanofi Winthrop Industrie as a party following a corporate merger, under R. 310 RoP. The order addressed the allocation of court fees and costs between multiple claimant entities in relation to the French territory claims.
Show the legal issues (3)
- Change of party following corporate merger / dissolution (R. 310 RoP)
- Allocation of court fees among multiple claimants
- R. 305 RoP application in pharmaceutical proceedings
Documents
- 67439B79516106DD4BFDCB68F1C1ACE9_en.pdf2025-01-07EN